IL6 and COVID-19: For these reason, numerous randomized clinical trials are currently underway to explore the effectiveness of biopharmaceutical drugs, such as, interleukin-6 inhibitors, interleukin-1 blockers, Janus kinase inhibitors, in COVID-19.